Danaher Co. (NYSE:DHR) Shares Purchased by Fiduciary Group LLC

Fiduciary Group LLC raised its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 164.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,152 shares of the conglomerate's stock after acquiring an additional 11,906 shares during the quarter. Fiduciary Group LLC's holdings in Danaher were worth $4,431,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Walkner Condon Financial Advisors LLC increased its holdings in shares of Danaher by 6.6% in the third quarter. Walkner Condon Financial Advisors LLC now owns 906 shares of the conglomerate's stock worth $225,000 after purchasing an additional 56 shares during the last quarter. One Day In July LLC increased its holdings in shares of Danaher by 1.7% in the third quarter. One Day In July LLC now owns 3,256 shares of the conglomerate's stock worth $808,000 after purchasing an additional 55 shares during the last quarter. Schmidt P J Investment Management Inc. increased its holdings in shares of Danaher by 13.1% in the third quarter. Schmidt P J Investment Management Inc. now owns 1,816 shares of the conglomerate's stock worth $451,000 after purchasing an additional 211 shares during the last quarter. Avestar Capital LLC increased its holdings in shares of Danaher by 32.1% in the third quarter. Avestar Capital LLC now owns 1,404 shares of the conglomerate's stock worth $348,000 after purchasing an additional 341 shares during the last quarter. Finally, Ascent Wealth Partners LLC increased its holdings in shares of Danaher by 10.8% in the third quarter. Ascent Wealth Partners LLC now owns 1,250 shares of the conglomerate's stock worth $310,000 after purchasing an additional 122 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently commented on DHR shares. Robert W. Baird lifted their price target on Danaher from $259.00 to $271.00 and gave the stock an "outperform" rating in a research report on Wednesday. Raymond James lifted their price target on Danaher from $240.00 to $270.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 31st. TD Cowen lifted their price target on Danaher from $280.00 to $290.00 and gave the stock a "buy" rating in a research report on Wednesday. Bank of America lifted their price target on Danaher from $258.00 to $270.00 and gave the stock a "neutral" rating in a research report on Wednesday. Finally, Barclays lifted their price target on Danaher from $260.00 to $270.00 and gave the stock an "equal weight" rating in a research report on Wednesday. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $269.64.

Danaher Trading Up 0.3 %

Shares of Danaher stock traded up $0.78 on Friday, hitting $246.58. 2,710,446 shares of the company traded hands, compared to its average volume of 2,710,897. The stock's 50 day moving average price is $248.87 and its 200-day moving average price is $231.27. The company has a current ratio of 1.85, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The company has a market cap of $182.64 billion, a PE ratio of 41.79, a PEG ratio of 3.79 and a beta of 0.83.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. During the same quarter in the previous year, the firm posted $2.36 earnings per share. The company's revenue was down 2.6% on a year-over-year basis. Equities research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from Danaher's previous quarterly dividend of $0.24. Danaher's payout ratio is currently 18.31%.

Insider Buying and Selling

In related news, CEO Rainer Blair sold 47,175 shares of the business's stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the completion of the transaction, the chief executive officer now owns 115,995 shares of the company's stock, valued at $28,908,273.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Daniel Raskas sold 23,757 shares of the company's stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares of the company's stock, valued at $9,601,704. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Rainer Blair sold 47,175 shares of the company's stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the transaction, the chief executive officer now directly owns 115,995 shares in the company, valued at $28,908,273.90. The disclosure for this sale can be found here. Insiders sold 106,565 shares of company stock valued at $26,641,364 over the last 90 days. Corporate insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.